European Medicines Agency Board
GPTKB entity
Statements (72)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Board
|
| gptkbp:addresses |
antimicrobial resistance
public concerns |
| gptkbp:advises |
gptkb:European_Commission
|
| gptkbp:advocatesFor |
public health interests
|
| gptkbp:approves |
marketing authorizations
|
| gptkbp:collaboratesWith |
research organizations
|
| gptkbp:composedOf |
members
|
| gptkbp:conducts |
scientific research
public consultations risk assessments |
| gptkbp:contributedTo |
public health
sustainable healthcare |
| gptkbp:coordinates |
scientific advice
|
| gptkbp:engagesIn |
regulatory bodies
industry stakeholders scientific community healthcare_professionals patient organizations |
| gptkbp:ensures |
compliance with regulations
ethical standards safety monitoring |
| gptkbp:established |
gptkb:European_Union
|
| gptkbp:evaluates |
therapeutic benefits
pharmaceutical innovations |
| gptkbp:facilitates |
data sharing
stakeholder engagement information sharing cross-border cooperation patient involvement |
| https://www.w3.org/2000/01/rdf-schema#label |
European Medicines Agency Board
|
| gptkbp:influences |
regulatory policies
|
| gptkbp:issues |
recommendations
public statements |
| gptkbp:meets |
regularly
|
| gptkbp:monitors |
market trends
clinical outcomes drug safety |
| gptkbp:oversees |
medicinal products
|
| gptkbp:participatesIn |
policy development
international collaborations |
| gptkbp:partOf |
gptkb:European_Medicines_Agency
|
| gptkbp:promotes |
innovation
patient safety transparency evidence-based medicine global health |
| gptkbp:provides |
guidance
training programs expert opinions technical assistance scientific expertise regulatory advice advice on safety |
| gptkbp:publishes |
guidelines
|
| gptkbp:responsibleFor |
scientific evaluation
|
| gptkbp:reviews |
clinical trials
post-marketing studies drug applications safety data |
| gptkbp:supports |
public health initiatives
healthcare policies research initiatives clinical research regulatory science health technology assessments patient access healthcare_innovation |
| gptkbp:worksOn |
drug development
vaccine evaluation |
| gptkbp:worksWith |
international agencies
national authorities |